Ticopol

  • Is a usefull glycopeptide currently used for the treatment of methicillin-resistant Staphylococcus aureus (MRSA).
  • Frequently administered to treat Gram-positive infections in pediatric patients.
  • Has the Same in vitro sensitive as vacomycin against methicillin-senssitive S. aureus, methicillin-resisitant S. aureus and enterococci in clinical isolates.
  • Widely used in clinical practice for the treatment of infections caused by drug resistant Gram-positive bacteria.